Skip to content

Clinical trials

Phase 2 Cardiovascular Diseases trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Phase: Phase 2 Country / region: United Kingdom Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20081
20093
20122
20151
20161
20183
20192
20223
20244

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Terminated4
Active, not recruiting3
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cardurion Pharmaceuticals, Inc.3
Complexa, Inc.2
Alnylam Pharmaceuticals1
BTG International Inc.1
Barts & The London NHS Trust1
Cambridge University Hospitals NHS Foundation Trust1
Celladon Corporation1
Manchester University NHS Foundation Trust1
Massachusetts General Hospital1
Novartis1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases22
Hypertension5
Heart Diseases4
Heart Failure4
Hypertension, Pulmonary3
Lung Diseases3
Vascular Diseases3
Atherosclerosis2
Connective Tissue Diseases2
Diabetes Mellitus, Type 22

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.